
    
      A Phase 1, Double-Blind, Placebo-Controlled, Randomized Single and Multiple Ascending Dose
      Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Exploratory
      Pharmacodynamics of Oral BMS-986318 Administration in Healthy Participants
    
  